• Available Technologies
• Resources
  • Our Process
  • Inventors
  • Industry
  • Entrepreneurs
  • Students
  • Policies
  • Forms & Documents
  • Agreement Types
  • Glossary
  • Links
• News and Events
  • News
  • Events
  • Press Releases
  • Success Stories
  • TECHcast
  • Drug Pipeline
  • Medical Device Pipeline
• About Us
  • Contact Us
  • Staff Directory
  • Facts & Figures
  • Annual Reports

• News
• Events
• Press Releases
• Success Stories
• TECHcast
• Drug Pipeline
• Medical Device Pipeline

Home > News & Events > News Articles > Article Details

Turning Emerging Science Into Investment Opportunity is the Focus of Biomed Exo, October 26, 2000

(Ann Arbor, Michigan)-- BioMed Expo: The Road to Success is planned for Thursday, October 26, 2000 in Ypsilanti, Michigan. The daylong event is being presented by the University of Michigan, Michigan Economic Development Corporation, Wayne State University, Van Andel Institute and Michigan State University.

The Expo will highlight resources available in Michigan to biomedical entrepreneurs. Focus will be on all aspects of commercializing biomedical technology, including starting a company, funding, licensing, technology transfer and industry collaboration.

BioMed Expo will be open from 8:30 a.m. to 5:30 p.m. at Eastern Michigan University's Convocation Center in Ypsilanti. Following the Expo from 6:00 to 9:00 p.m., attendees are invited to open house events at Genomic Solutions Inc. and Esperion Therapeutics, Inc., both Ann Arbor-based life sciences companies that had recent, successful IPOs. These companies showcase the culmination of biomedical technology commercialization in Michigan.

BioMed Expo was conceived by a task force of leaders from Michigan-based biomedical companies and universities. It is an initiative of Michigan's "Life Sciences Corridor," which was created in July 1999 to fund life sciences research, development, collaboration and commercialization in Michigan.

The life sciences industry is targeted for high-technology development in the state. "The BioMed Expo is a great opportunity for researchers, clinicians, entrepreneurs and industry representatives from the private and public sectors who have an interest in launching or growing biomedical companies," says Lisa Kurek of Biotechnology Business Consultants, the Expo management firm. "Michigan has an exceptionally strong base of core technology emanating from its universities, which are well known for their depth and breadth of biomedical research."

The BioMed Expo will feature speakers, workshops and exhibits in a highly interactive setting and encompassing the full range of resources necessary for success in the biomedical industry.

Keynote speakers will be Carl Feldbaum, President, Biotechnology Industry Organization and W. Steven Burke, Sr., Senior Vice President, North Carolina Biotechnology Center. A variety of hands-on workshops will address issues critical to the successful commercialization of new technologies. Workshops include:

• SBIR/STTR Grants: How to get Funded, presented by Alan Berson, President, Bioengineering Research Group and a former Deputy Chief at the National Heart, Lung & Blood Institute; Mickey Katz-Pek, Managing Partner, Biotechnology Business Consultants, LLC.

• Regulatory Approval/Licensing New Products, presented by Stephen Goldner, JD., Vice-President, Regulatory Affairs, Ferndale Laboratories, Inc.

• When and How to Approach Big Pharma for Partnerships and Collaboration, presented by David Herzig, PhD., private consultant to the biotechnology and pharmaceutical industry and former Vice-President for Drug Development and Scientific Development for Parke-Davis; Jerry A. Weisbach, PhD., Director for Technology Transfer for Rockefeller University and private consultant to the biotechnology and pharmaceutical industry.

• Transitioning from Academia to Start-up, presented by Russell Medford, President & CEO, Atherogenics; Roger Newton, President, Esperion Therapeutics, Inc.

• University Spin-offs � Licensing Dynamics, presented by Michael Lytton, Palmer & Dodge, LLC; Fred Rienhart, Wayne State University.

• Going for the Gold: Early Stage Financing, presented by Tom Churchwell, Arch Development; Pat Snider, BioVentures Development Partners, LLC.

• Planning for an Initial Public Offering, presented by Jeff Williams, President & CEO, Genomic Solutions Inc.; Steve Richvalsky, CFO, Genomic Solutions Inc.; Peter Sugar, Senior Securities and Corporate Lawyer, Jaffee, Raitt, Heuer & Weiss; David Volk, Managing Director, Corporate Finance, Dain, Rauscher, Wessels.

• Michigan Life Sciences Corridor: Q & A, presented by Doug Rothwell, President and CEO, Michigan Economic Development Corporation; Michael A. Finney, Vice President, Emerging Business Sectors, MEDC; Michele van de Walle, Life Sciences Business Development Manager, MEDC.

• How to Get Your Plan Funded: Pitching to Venture Capital Firms, presented by Tom Collett, TD Lighthouse Capital Fund, Tullis Dickerson & Company; Christine Gibbons, Partner and CFO, Seaflower Ventures; Tom Porter, EDF Ventures.

• Intellectual Property and Patent Strategies, presented by Peter Carroll, Medlen and Carroll.

A large number of exhibitors will also be on hand representing the life sciences industry, academic and research institutions, venture capital, patent and general business attorneys, business consulting and services firms, not-for-profit business resources, and university technology transfer offices.